Month: October 2013

VIENNA (Reuters) – Infants and children can be more at risk than adults of developing some cancers when exposed to radiation, for example from nuclear accidents, a U.N. scientific report said on Friday. Children were found to be more sensitive than adults for the development of 25 percent of tumor types including leukemia, and thyroid, brain and breast cancer, it said. “The risk can be significantly higher, depending on circumstances,” the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) added in a statement. …

Some of them are shapely and healthy looking, and look good on camera. … Celebrity slim diet, the basic idea is to educate people and not to depict food as an …

The researchers found those who underwent surgery lost more weight and received greater health benefits than those who had non-surgical treatments like diet …

A Futurehunter Examines the Dangers of Stock Trading at the Speed of Light [Excerpt]

BRUSSELS (Reuters) – Belgian pharmaceutical group UCB said on Friday that European regulators have recommended approval of its Cimzia drug for treating psoriatic arthritis in adults. UCB said that the condition affected an estimated 24 out of 10,000 people, usually between the ages of 30 and 50, and up to 30 percent of psoriasis patients. The news follows the approval by the European Medicine Agency’s Committee for Medical Products for Human Use (CHMP) for Cimzia to treat adults with severe active axial spondyloarthritis. …

(Reuters) – Abbott Laboratories said on Friday that the U.S. Food and Drug Administration approved its MitraClip medical device, used to stop heart valve leakage. A slim majority of advisers to the FDA had recommended approval of the implantable heart device, as some had questioned whether it would be effective for its intended use. The device was already approved for use in Europe and sells in 30 countries. …

LONDON (Reuters) – European regulators have recommended approval of Swiss firm Actelion’s new pulmonary arterial hypertension drug Opsumit and a novel antidepressant called Brintellix from Denmark’s Lundbeck. The green light for Opsumit comes hard on the heels of its approval in the United States last week and buttresses Actelion’s position as a leading player in treating pulmonary arterial hypertension (PAH). Opsumit is a successor to Actelion’s established medicine Tracleer, which loses patent protection in 2015. …

By Erika Solomon BEIRUT (Reuters) – Lebanon, which hosts more than 700,000 Syrian refugees, said on Friday it would vaccinate all children under five against polio after suspected cases of the crippling viral disease were found in neighboring Syria. The World Health Organization (WHO) said on Thursday at least 22 people had acute flaccid paralysis, a symptom of diseases including polio, in Syria’s eastern Deir al-Zor province, which borders Iraq, most of them children. …

(Reuters) – The U.S. Food and Drug Administration said on Friday it is issuing a proposed rule aimed at improving the safety of food for animals and pets. The rule would require companies that make animal feed and pet food sold in the United States to identify potential hazards and put in place procedures to prevent and correct them. The rule is one of seven key pillars of the 2011 Food Safety Modernization Act, an initiative designed to improve human and animal food safety and reduce food-borne illnesses by giving the FDA greater power to intervene before an outbreak occurs. …

We'll be asking volunteers to eat a calorie-controlled diet that includes main meals and healthy snacks. “Our hope is that the information we gain from the study …

By Toni Clarke WASHINGTON (Reuters) – The U.S. Food and Drug Administration on Thursday recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such as Vicodin. Until now, Vicodin and other products that contain less than 15 milligrams of hydrocodone have been classified as Schedule III controlled substances. The FDA recommends reclassifying them more restrictively — potentially as Schedule II products, in line with opioid pain-killers such as oxycodone and morphine. …